Follow-up of Favipiravir-Induced Nail Fluorescence: Implications for Nail and Drugs

被引:1
作者
Guder, Husna [1 ,3 ]
Ozunal, Zeynep Gunes [2 ]
机构
[1] Maltepe Univ, Med Fac, Dept Dermatol, Istanbul, Turkiye
[2] Maltepe Univ, Med Fac, Dept Pharmacol, Istanbul, Turkiye
[3] Maltepe Univ, Med Fac, Dept Dermatol, Feyzullah Caddesi 39, Istanbul, Turkiye
来源
DERMATOLOGY PRACTICAL & CONCEPTUAL | 2023年 / 13卷 / 01期
关键词
favipiravir; nail; fluorescence; drug; PHARMACOKINETICS;
D O I
10.5826/dpc.1301a11
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Introduction: Favipiravir creates fluorescence on nails, which can be seen with Wood's light. Objectives: The objectives of this study are to examine the properties of fluorescence in the nail due to favipiravir and to observe whether other drugs also produce fluorescence in the nail. Methods: The research is descriptive, prospective, and quantitative. This study recruited 30 healthcare workers who received favipiravir treatment and 30 volunteers who took or did not take any medication except favipiravir from March 2021 to December 2021. Fingernails of the patients and control groups were examined under Wood's light in the darkroom. If fluorescence was observed in the fingernails, we followed up once a month until the fluorescence disappeared. We calculated the nail growth rate by dividing the distance of nail fluorescence from the proximal nail fold by the number of days since favipiravir was started. Results: We found nail fluorescence in all patients receiving a loading dose of favipiravir. The fluorescence in the nail decreased and disappeared in the 3rd month. The average nail growth rate at the first visit was 0.14 mm/day. The nail growth rate at the second visit was 0.10 mm/day. A statistically significant difference was found between the first and second visit nail growth rates (z:-2.576; p=0.010<0.05). We found that other drugs did not produce any fluorescence in the nail. Conclusions: Nail fluorescence induced by favipiravir is dose-dependent and decreases in intensity over time. Nail fluorescence due to favipiravir is likely due to the active ingredient of the drug.
引用
收藏
页数:8
相关论文
共 20 条
  • [1] Fluorescence of nails and hair on Wood's lamp examination in Covid pandemic; undefined effect of Favipiravir in humans
    Aslan Kayiran, Melek
    Cebeci, Filiz
    Erdemir, Vefa Asli
    Aksoy, Hasan
    Akdeniz, Necmettin
    Gurel, Mehmet Salih
    [J]. DERMATOLOGIC THERAPY, 2021, 34 (01)
  • [2] Understanding the formidable nail barrier: A review of the nail microstructure, composition and diseases
    Baswan, Sudhir
    Kasting, Gerald B.
    Li, S. Kevin
    Wickett, Randy
    Adams, Brian
    Eurich, Sean
    Schamper, Ryan
    [J]. MYCOSES, 2017, 60 (05) : 284 - 295
  • [3] Pharmacokinetics of antifungal agents in onychomycoses
    Debruyne, D
    Coquerel, A
    [J]. CLINICAL PHARMACOKINETICS, 2001, 40 (06) : 441 - 472
  • [4] Wood's lamp examination of hair and nails related to COVID-19 treatment
    Demir, Betul
    Cicek, Demet
    Turkoglu, Sedatcan
    Bozdemir, Neslihan Yuksel
    Sarikurt, Furkan
    Banoglu, Erden
    [J]. DERMATOLOGIC THERAPY, 2021, 34 (06)
  • [5] Favipiravir: Pharmacokinetics and Concerns About Clinical Trials for 2019-nCoV Infection
    Du Yin-Xiao
    Chen Xiao-Ping
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 108 (02) : 242 - 247
  • [6] Modulation of linear nail growth to treat diseases of the nail
    Geyer, AS
    Onumah, N
    Uyttendaele, H
    Scher, RK
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (02) : 229 - 234
  • [7] Guder H., 2021, JOJ DERMATOL COSMET, V3, P79, DOI DOI 10.19080/JOJDC.2021.03.555619
  • [8] Yellow-white fluorescence on the nails: A novel finding of Favipiravir used for the treatment of COVID-19
    Gulseren, Duygu
    Yalici-Armagan, Basak
    [J]. JOURNAL OF COSMETIC DERMATOLOGY, 2021, 20 (08) : 2392 - 2393
  • [9] The efficacy and safety of pulse vs. continuous therapy for dermatophyte toenail onychomycosis
    Gupta, A. K.
    Stec, N.
    Bamimore, M. A.
    Foley, K. A.
    Shear, N. H.
    Piguet, V.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2020, 34 (03) : 580 - 588
  • [10] YELLOW LUNULAE WITH FLUORESCENCE AFTER TETRACYCLINE THERAPY
    HENDRICKS, AA
    [J]. ARCHIVES OF DERMATOLOGY, 1980, 116 (04) : 438 - 440